Imatinib trough levels in chronic myelogenous leukemia: does one dose fit all?

Leuk Lymphoma. 2011 Feb;52(2):165-7. doi: 10.3109/10428194.2010.540362. Epub 2010 Dec 20.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Gastric Bypass
  • Humans
  • Imatinib Mesylate
  • Intestinal Absorption / drug effects
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate